Cambridge Investment Research Advisors Inc. Has $5.80 Million Stake in The Clorox Company (NYSE:CLX)

Cambridge Investment Research Advisors Inc. trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 13.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,475 shares of the company’s stock after selling 6,611 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Clorox were worth $5,797,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Venturi Wealth Management LLC increased its holdings in Clorox by 308.5% during the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after purchasing an additional 145 shares in the last quarter. Northwest Financial Advisors acquired a new stake in Clorox during the 4th quarter valued at $29,000. Core Wealth Advisors Inc. acquired a new stake in Clorox during the 4th quarter valued at $29,000. First United Bank & Trust bought a new position in Clorox in the 4th quarter valued at $31,000. Finally, GoalVest Advisory LLC bought a new position in Clorox in the 1st quarter valued at $31,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

CLX opened at $155.44 on Thursday. The business’s 50-day moving average price is $139.38 and its two-hundred day moving average price is $142.41. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $158.89. The company has a market capitalization of $19.30 billion, a price-to-earnings ratio of 80.54, a P/E/G ratio of 1.97 and a beta of 0.39. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 382.58% and a net margin of 3.95%. The firm had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Equities analysts expect that The Clorox Company will post 6.4 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Wednesday, August 14th will be given a $1.22 dividend. The ex-dividend date of this dividend is Tuesday, August 13th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.14%. This is an increase from Clorox’s previous quarterly dividend of $1.20. Clorox’s payout ratio is currently 252.85%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CLX. DA Davidson decreased their price objective on Clorox from $162.00 to $153.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. JPMorgan Chase & Co. decreased their price objective on Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft increased their price objective on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Barclays increased their price objective on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Finally, Wells Fargo & Company reduced their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Six investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $143.19.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.